Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-020272
Filing Date
2015-03-31
Accepted
2015-03-31 17:18:43
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v404663_10k.htm 10-K 777968
2 EXHIBIT 10.20 v404663_ex10-20.htm EX-10.20 246476
3 EXHIBIT 31.1 v404663_ex31-1.htm EX-31.1 11109
4 EXHIBIT 31.2 v404663_ex31-2.htm EX-31.2 10919
5 EXHIBIT 32.1 v404663_ex32-1.htm EX-32.1 5584
6 GRAPHIC tex10-20logo.jpg GRAPHIC 6254
  Complete submission text file 0001144204-15-020272.txt   6915442

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT adhxf-20141231.xml EX-101.INS 1178660
8 XBRL TAXONOMY EXTENSION SCHEMA adhxf-20141231.xsd EX-101.SCH 60512
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adhxf-20141231_cal.xml EX-101.CAL 25145
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adhxf-20141231_def.xml EX-101.DEF 269258
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE adhxf-20141231_lab.xml EX-101.LAB 336102
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adhxf-20141231_pre.xml EX-101.PRE 306746
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32295 | Film No.: 15740386
SIC: 2836 Biological Products, (No Diagnostic Substances)